0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Advancements in Biologics Revolutionize the Neuromyelitis Optica Treatment MarketExecutive Summary Neuromyelitis Optica Treatment Market Research: Share and Size Intelligence The global neuromyelitis optica treatment market size was valued at USD 297.72 million in 2024 and is projected to reach USD 503.94 million by 2032, with a CAGR of 6.80% during the forecast period of 2025 to 2032. The large scale Neuromyelitis Optica Treatment Market report gives...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Biologics and ADC Innovations Power High Potent Pharmaceuticals Product Market GrowthThe global High Potent Pharmaceuticals Product Market is witnessing substantial growth due to increasing demand for targeted therapies, rising prevalence of chronic diseases, and expanding oncology drug development activities. High potent pharmaceutical products are widely used in the treatment of cancer, hormonal disorders, and various chronic conditions due to their high therapeutic efficacy...0 Commentaires 0 Parts 77 Vue 0 Aperçu
-
Biologics CDMO Market: Contract Manufacturing Trends and Growth OpportunitiesBiologics Contract Development And Manufacturing Organization (CDMO) Market Summary: According to the latest report published by Data Bridge Market Research, the Biologics Contract Development And Manufacturing Organization (CDMO) Market CAGR Value The global biologics contract development and manufacturing organization (CDMO) market size was valued at USD 16.61 billion in...0 Commentaires 0 Parts 103 Vue 0 Aperçu
-
Biologics CDMO Market: Outsourcing Trends and Industry DevelopmentsExecutive Summary Biologics Contract Development and Manufacturing Organization (CDMO) Market Size and Share: Global Industry Snapshot CAGR Value The global biologics contract development and manufacturing organization (CDMO) market size was valued at USD 16.61 billion in 2024 and is expected to reach USD 38.27 billion by 2032, at a CAGR of 11.00% during...0 Commentaires 0 Parts 322 Vue 0 Aperçu
-
Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Share, Trends, Key Drivers and Competitive OutlookBiologics Contract Development and Manufacturing Organization (CDMO) Market Segmentation, By Product Type (Gene Products, Vaccines, Stem Cells, Monoclonal Antibodies, and Others), Service Type (Manufacturing, Research and Development, Clinical Trials, and Others), End-Users (Biotechnology Companies, Biopharmaceutical Companies, and Others) - Industry Trends and Forecast to 2032 Biologics...0 Commentaires 0 Parts 853 Vue 0 Aperçu
-
Biologics Market Size Projected to Reach USD 1230.70 Billion by 2032“According to a new report published by Introspective Market Research, Biologics Market by Product Type, Application, and Manufacturing, The Global Biologics Market Size Was Valued at USD 509.3 Billion in 2023 and is Projected to Reach USD 1230.70 Billion by 2032, Growing at a CAGR of 10.3%.” Biologics, short for biological products, represent a transformative class of medicines...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Biologics Virus Filtration Market Overview: Key Drivers and ChallengesMarket Trends Shaping Executive Summary Biologics Virus Filtration Market Size and Share CAGR Value Global biologics virus filtration market size was valued at USD 2,316.72 million in 2024 and is projected to reach USD 5,082.85 million by 2032, with a CAGR of 10.32% during the forecast period of 2025 to 2032. Biologics Virus Filtration report has been formulated by keeping in...0 Commentaires 0 Parts 502 Vue 0 Aperçu
-
Biologics Virus Filtration Market: Size, Share, and Future GrowthExecutive Summary Biologics Virus Filtration Market Size and Share Across Top Segments CAGR Value Global biologics virus filtration market size was valued at USD 2,316.72 million in 2024 and is projected to reach USD 5,082.85 million by 2032, with a CAGR of 10.32% during the forecast period of 2025 to 2032. Analysis and discussion of important industry trends, market size, and...0 Commentaires 0 Parts 359 Vue 0 Aperçu
-
Biosimilars and Follow-on Biologics Market to 2035 | USD 145.2B Growth at 14.1% CAGRThe global Biosimilars and Follow-on Biologics Market is witnessing rapid expansion, with market value estimated at USD 38.7 billion in 2025 and projected to reach USD 145.2 billion by 2035, growing at a CAGR of 14.1% during the forecast period. Growth is being driven by rising demand for cost-effective biologic therapies, increasing patent expirations of blockbuster biologic drugs, expanding...0 Commentaires 0 Parts 16 Vue 0 Aperçu
-
How Innovation in Biologics and Gene Therapy Is Shaping the Future of the Multiple Sclerosis Market?Global Executive Summary Multiple Sclerosis Market: Size, Share, and Forecast CAGR Value The global multiple sclerosis market was valued at USD 28.28 billion in 2024 and is expected to reach USD 37.96 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 3.75%, primarily driven by the anticipated launch of new therapies and advancements in...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Injection Devices for Biologics Market: Advancing Drug Delivery TechnologiesInjection Devices for Biological Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Injection Devices for Biological Drugs Market CAGR Value The global injection devices for biological drugs market size was valued at USD 568.77 billion in 2025 and is expected to reach USD 1,124.19 billion by 2033, at...0 Commentaires 0 Parts 214 Vue 0 Aperçu
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Commentaires 0 Parts 255 Vue 0 Aperçu
-
Asia-Pacific Amniotic Products Market Expands with Rising Regenerative Medicine ApplicationsAsia-Pacific Amniotic Products Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Amniotic Products Market CAGR Value The large scale Asia-Pacific Amniotic Products Market report evaluates CAGR value fluctuation during the forecast period for the market. All the studies performed to generate this business report are based on large...0 Commentaires 0 Parts 6 Vue 0 Aperçu
-
Biosimilar Market Business Strategies: Navigating Pricing Compression in 2026Strategic Blueprint: The Global Biosimilar and Follow-On Biologics Market—Vision 2030 The 2026 Paradigm Shift: From Alternative to Essential As we stand in the midpoint of 2026, the global healthcare ecosystem has reached a definitive tipping point. The Global Biosimilar and Follow-on Biologics Market is no longer a peripheral sector of the pharmaceutical industry; it has become the...0 Commentaires 0 Parts 250 Vue 0 Aperçu
-
How the Ustekinumab Market Is Redefining Biologic Therapies for Autoimmune Diseases?Executive Summary Ustekinumab Market Opportunities by Size and Share CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market research report is a verified and consistent source of information that puts forth a telescopic view of the...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Is the EPO Drugs Market Expanding with Advancements in Anemia Treatment?Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Commentaires 0 Parts 744 Vue 0 Aperçu
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Rising Prevalence of Eye Disorders Drives Innovation in the Global Retinal Biologics Market"Executive Summary Retinal Biologics Market Size and Share Forecast Data Bridge Market Research analyses a growth rate in the retinal biologics market in the forecast period 2023-2030. The expected CAGR of retinal biologics market tends to be around 11.6% in the mentioned forecast period. The market was valued at USD 22.2 billion in 2022 and would grow to USD 53.42 billion by...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Will HER2 Inhibitors Continue to Revolutionize Targeted Cancer Therapy?HER2 Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the HER2 Inhibitors Market CAGR Value With the clear understanding of customer requirement, one method or combination of many have been used to construct the most excellent HER2 Inhibitors Market research report. The report endows with complete market analysis and...0 Commentaires 0 Parts 449 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek